MedPage Today on MSN
First TAVR System Approved for Severe Aortic Regurgitation
Limited launch expected for JenaValve's Trilogy System ...
The FDA PMA for JenaValve's Trilogy device for TAVR-AR comes months after a court struck down Edwards Lifesciences attempt to ...
The approval comes two months after Edwards Lifesciences scuttled plans to buy JenaValve for $945 million amid opposition ...
A patient in the United States has become the first in the country to receive Corcym's next-generation Perceval Plus(R) LANCELOT sutureless aortic valve, marking an important milestone in the ...
JenaValve's Trilogy System, FDA-approved for severe AR, offers secure anchoring without calcium. It is a breakthrough for ...
JenaValve has secured the FDA’s approval for its minimally invasive heart implant, making it the first to claim a U.S. green light to treat severe backflow through the aortic valve. | JenaValve has ...
JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket ...
New evidence shows regular aspirin use is associated with a lower incidence of aortic valve calcification and aortic stenosis ...
Terumo Aortic announced that the FDA has granted Breakthrough Device designation for the company’s fenestrated Treo abdomin ...
Thoracic aortic dissection is often approached as an acute and localised event, and pathological examination has traditionally focused on the dissected segment. In daily practice, however, most ...
BACKGROUND: Aortic valve calcification increases leaflet stiffness and contributes to the development of calcific aortic valve disease. The molecular and cellular mechanisms underlying calcification ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results